MGK vs XBI
Vanguard Mega Cap Growth ETF vs SPDR S&P Biotech ETF
MGK$87.31
Vanguard Mega Cap Growth ETF
Mega-cap US growth stocks.
Expense: 0.05%Yield: 0.35%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • MGK has the lower expense ratio at 0.05% vs 0.35% for XBI.
Side-by-side metrics
| Metric | MGK | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.05% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.35% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $32.99B | $10.92B |
YTD return | 4.51% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.24 | 1.01 |
P/E ratio | 29.31 | — |
Last price | $87.31 | $156.41 |
Inception | — | — |
Issuer | Vanguard | State Street |
MGK top holdings
Top holdings · MGK
| NVDA | NVIDIA Corp | 13.69% |
| AAPL | Apple Inc | 12.53% |
| MSFT | Microsoft Corp | 9.46% |
| GOOGL | Alphabet Inc Class A | 4.98% |
| META | Meta Platforms Inc Class A | 4.96% |
| AVGO | Broadcom Inc | 4.30% |
| AMZN | Amazon.com Inc | 4.23% |
| GOOG | Alphabet Inc Class C | 3.95% |
| AMD | Advanced Micro Devices Inc | 3.22% |
| TSLA | Tesla Inc | 3.14% |
Sector breakdown · MGK
Real Estate1.2%
Consumer Cyclical9.6%
Basic Materials0.4%
Consumer Defensive0.4%
Technology62.0%
Communication Services15.4%
Financial Services4.1%
Industrials2.4%
Healthcare4.4%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About MGK
MGK (Vanguard Mega Cap Growth ETF) is Mega-cap US growth stocks. Managed by Vanguard, the fund carries $33.0B in assets under management, an expense ratio of 0.05%, a dividend yield of 0.35%. Its largest holding is NVIDIA Corp (NVDA), which represents 13.7% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.